Cleveland, OH, October 17, 2024 - Rymedi and My One Medical Source® (MOMS), an innovative platform empowering labs and other clients to connect with nearly 2,000 independent MAPs: Medical Access Points/Providers™, have announced a partnership. The MOMS platform enables participants to have convenient specimen collection options expanding the reach for laboratories. Rymedi will power MOMS on its blockchain platform, creating an immutable electronic chain of custody for each step in the sample collection process. Together, they are combining their retrospective strengths to provide participants, laboratories and other stakeholders a consistent experience from order generation, specimen collection and results delivery.
"MOMS is excited to partner with Rymedi and their technologically advanced offerings. Their approach to the ordering process compliments MOMS' ability to get specimens collected in a unique way from which the industry will benefit," said Brad Seybert, CEO/Founder of MOMS. "Rymedi aligns with our philosophy that Better Access leads to Better Outcomes, and they provide functionality that drives the mission forward."
David Stefanich, CEO of Rymedi, expressed his enthusiasm for the collaboration by saying "Rymedi is excited to join forces with My One Medical Source to make lab testing more accessible. Together, we're creating a more efficient and transparent lab testing experience."
Rymedi and MOMS will appear together at the HLTH USA Conference in Las Vegas, NV, October 20-23, 2024. Click the link below to learn more about this innovative healthcare ecosystem designed to increase access and the process for lab testing availability.
About MOMS
MOMS is an innovative platform empowering labs and other clients to connect with MAPs: Medical Access Points/Providers™ that have the skilled labor needed to perform compliant and convenient specimen collections. We believe that Better Access leads to Better Outcomes.
For more information, visit www.myonemedicalsource.com.
About Rymedi
Founded in 2018 as a blockchain-enabled software as a service (SAAS) company, Rymedi enables life science organizations to improve human health. Rymedi's patient and population health data management software supports clinical trials and patient registries, clinical diagnostic and toxicology clinical trials and patient registries, clinical lab integrations, and the secure and compliant storage of healthcare data. Rymedi's platform runs on three separate Avalanche blockchain subnets, providing an incredibly powerful L1 blockchain infrastructe for decentralized science. For more information, please visit www.rymedi.com.
